-+ 0.00%
-+ 0.00%
-+ 0.00%

Xenetic Biosciences Extends Research Agreement With University of Virginia For Advancement Of DNase-Based Oncology Platform

Benzinga·12/16/2024 14:07:04
Listen to the news

Company continuing to advance DNase-based oncology program towards clinical proof-of-concept studies in multiple indications